Osteoarthritis trial results boost Paradigm shares and treatment hopes
MELBOURNE: Shares in listed drug repurposing business Paradigm Biopharmaceuticals surged 19 per cent on Tuesday
MELBOURNE: Shares in listed drug repurposing business Paradigm Biopharmaceuticals surged 19 per cent on Tuesday